Clinical Research Directory
Browse clinical research sites, groups, and studies.
Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa
Sponsor: Peking Union Medical College
Summary
This study aims to retrospectively analyze the efficacy and safety of secukinumab combined with surgery in treating moderate to severe HS in real-world clinical practice, providing clinical practioners with real-world evidence in HS treatment.
Official title: Efficacy and Safety of Secukinumab in Conjunction With Surgery in Moderate to Severe Hidradenitis Suppurativa: An Open-label Cohort Study in Real Clinical Practice
Key Details
Gender
All
Age Range
Any - 80 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2020-01-01
Completion Date
2025-06-21
Last Updated
2025-04-16
Healthy Volunteers
No
Interventions
Surgery combined with secukinumab
Surgery combined with secukinumab
Locations (1)
Hospital for Skin Diseases, Institute of Dermatology, Chinese Academy of Medical Science and Peking Union Medical College
Nanjing, Jiangsu, China